# Pharmacy Shared Resource

> **NIH NIH P30** · MAYO CLINIC ROCHESTER · 2021 · $129,151

## Abstract

PHARMACY SHARED RESOURCE PROJECT SUMMARY
The Mayo Clinic Cancer Center (MCCC) Pharmacy Shared Resource (PSR) provides comprehensive
pharmacy services in support of 358 open therapeutic clinical trials and 440 studies closed to enrollment with
ongoing activity at Mayo Clinic sites in Arizona, Florida and Rochester. The PSR provides pharmacy services
exclusively to MCCC members supporting the Clinical Research Programs. The Services of the PSR are
essential for protocol development, protocol initiation, and patient treatment on clinical trials. Services include
drug procurement, drug storage, and drug accountability of investigational agents assigned to the clinical trials.
The PSR is responsible for the preparation and/or sterile admixture of cytotoxic chemotherapy, biotherapy
(including targeted, virus/gene therapies, and immunomodulatory therapies), anti-emetics and supportive care
medications. The PSR assists the MCCC Clinical Research Office (CRO) in protocol development by providing
review and authorship of key sections in each protocol in development including treatment, dose modifications,
supportive care, drug-drug interactions and drug monograph sections. The PSR is working on ~130 protocols
currently in development. PSR pharmacists also conduct comprehensive medication management
consultations (MTM, electronic and in person) for MCCC patients registered to clinical trials to assess eligibility,
potential drug-drug interactions, appropriate alternative medications, and proper dosing of medications. PSR
pharmacists provide patient counseling for home-going oral investigational medications. The PSR staff has
expertise in investigational and commercially available cancer therapeutics ensuring a uniformly high standard
of safe and accurate treatment for all MCCC patients. The PSR director has 20 years of experience in
pharmacy with 18 years focused in hematology and oncology with extensive involvement in outside
organizations promoting the role of the pharmacist in the care of the cancer patient. For the current grant cycle,
147 MCCC members from 8 Programs used PSR services. Prior implementation of Mayo-wide policies and
procedures ensure that the PSR remains consistent with guidelines from the Food and Drug Administration,
National Cancer Institute, Investigational Review Board, American Society of Health Systems Pharmacy,
American College of Clinical Pharmacy, Hematology Oncology Pharmacy Association, State Boards of
Pharmacy, the United States Pharmacopeia (USP) and The Joint Commission. The PSR ensures regulatory
compliance and provides a uniform level of safe, high quality pharmaceutical care to all MCCC patients
enrolled on clinical trials.

## Key facts

- **NIH application ID:** 10113587
- **Project number:** 5P30CA015083-47
- **Recipient organization:** MAYO CLINIC ROCHESTER
- **Principal Investigator:** Heidi D Finnes
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $129,151
- **Award type:** 5
- **Project period:** 1997-04-25 → 2024-02-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10113587

## Citation

> US National Institutes of Health, RePORTER application 10113587, Pharmacy Shared Resource (5P30CA015083-47). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10113587. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*